Press Releases

 Filter by Provider

Oak Ridge, Tennessee--(Newsfile Corp. - April 20, 2026) - LIS Technologies Inc. ("LIST" or "the Company"), a proprietary developer of...

Xponential Fitness, a leading curator of globally and nationally recognized boutique health and wellness brands, announced today the signing of its largest multi-unit agreement in the company’s history. Riser Fitness has obtained the remaining territories in six states and has agreed to open 127 Club Pilates studios over the next five years. The agreement will expand Riser Fitness and Club Pilates’ reach in the following states:

Beijing, China--(Newsfile Corp. - April 20, 2026) - Ceres Holographics and Eastman, long-term innovation...

Peachtree Group (“Peachtree”) announced it has acquired over $330 million in loans year-to-date from U.S. banking institutions and private lenders which includes a lender finance transaction secured by portfolios of loans.

Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, today announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a more than threefold increase in synthesis capacity, enabling faster, more scalable production of high‑quality, customizable oligonucleotides that support next‑generation sequencing (NGS)‑based oncology workflows, including minimal residual disease (MRD) applications.

Fort Lauderdale, Florida--(Newsfile Corp. - April 20, 2026) - OptimumBank Holdings, Inc. (NYSE American: OPHC), announced today Brean Capital, LLC...

Investcorp Credit Management BDC, Inc. (NASDAQ: ICMB) (“ICMB” or the “Company”) today announced that it has engaged Houlihan Lokey, a leading independent investment bank, as its financial advisor to assist the Special Committee of Independent Directors in its ongoing review of strategic alternatives.

Detroit, Michigan--(Newsfile Corp. - April 20, 2026) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company"), a global leader in AI-driven...

PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”) today announced that Asahi Kasei Therapeutics (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Daisuke Okajima, hereinafter “Asahi Kasei Therapeutics”), its collaboration partner, has initiated a Phase 1 clinical trial*1 of “AK1940”, a selective inhibitor of TNF receptor 1 (“TNFR1”).

Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - 37 Capital Inc. (CSE: JJJ) ("37 Capital" or the "Company") announces...

Company executives will discuss their business strategies, provide updates on recent developments, and answer questions live at VirtualInvestorConferences.com

TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- 01 Quantum Inc. (“01 Quantum” or the “Company”) (TSX-V: ONE; OTCQB: OONEF), one of the first-to-market, enterprise level cybersecurity providers for the quantum computing era, announces that CEO Andrew Cheung will present live at the AI & Tech Virtual Investor Conference hosted by VirtualInvestorConferences.com, on April 23rd, 2026.

Knoxville, Tennessee--(Newsfile Corp. - April 20, 2026) - Clinch Resources Ltd. (TSX: CLCH) ("Clinch" or the "Company"), a metallurgical coal...

Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Phase 2 CALMA trial approaching completion

VANCOUVER, BC / ACCESS Newswire / April 20, 2026 / TripSitter Clinic Ltd. (the "Company" or "TripSitter") (CSE:KETA) announces that it has been identified by the plaintiffs as a respondent in discovery in connection with a negligence and wrongful death lawsuit filed in the State of Illinois.

A defining moment for the future of mental health, and for Biomind's mission to transform neuropsychiatric care through next-generation psychedelic medicines

Company secures Commitment Letter from a leading financial institution of up to $22.5M to finance proposed acquisition of Dura Control Systems (DCS)

34-Year CIA Veteran, Trailblazer Medal Recipient, and Pioneer of Groundbreaking Intelligence Capabilities Brings Unmatched Expertise in Secure Systems, RF Technologies, and Operational Security to Sekur's Leadership Team - Leading Sekur's entry into defense communications technology

$50 Million Tender Award is Part of $1.7 Billion Eastern Border Security Barrier Initiative Led by Israeli Ministry of Defense

MIAMI, FL / ACCESS Newswire / April 20, 2026 / Aimwell Partners (OTC Pink:AIMN) Aimwell Bio today officially opened applications for its exclusive Founding Cohort, a high-fidelity intelligence network designed to bridge the "Verification Gap" currently exposing medical practitioners and biopharma scientists to unprecedented professional risk.

PORT WASHINGTON, NY / ACCESS Newswire / April 20, 2026 / Global Industrial Company (NYSE:GIC), a value-added national distributor and source for industrial equipment and supplies, today announced that it will release financial results for the first quarter ended March 31, 2026, on Tuesday, May 5, 2026, after U.S. market hours.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - 01 Quantum Inc. (TSXV: ONE) (OTCQB: OONEF) ("01 Quantum" or the "Company"), one...

STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite Technologies Ltd.) [NSE: STLTECH], a leading connectivity solutions provider for AI-ready digital infrastructure, today announced the U.S. launch of Neuralis, its flagship suite of data center connectivity solutions, at Data Center World 2026 in Washington, D.C.

NETGEAR®, Inc. (NASDAQ: NTGR), a global leader in intelligent networking solutions designed to power extraordinary experiences, today announced that it will hold a conference call with investors and analysts on Wednesday, April 29 at 5:00 p.m. ET (2:00 p.m. PT) to discuss the Company’s first quarter 2026 results and second quarter 2026 business outlook.

Arlo Technologies, Inc. (NYSE: ARLO), a leading provider of smart security services, today announced that it will hold a conference call with investors and analysts on Thursday, May 7, 2026 at 5:00 p.m. ET (2:00 p.m. PT) to discuss the Company’s first quarter 2026 results. The news release announcing the first quarter 2026 results will be disseminated on May 7, 2026 after the market closes.

Sila Realty Trust, Inc. (NYSE: SILA) (“Sila”, the “Company”) and certain affiliates of Blue Owl Capital Inc. (NYSE: OWL) (“Blue Owl”) today announced that Sila has entered into a definitive merger agreement pursuant to which certain affiliates of Blue Owl Real Estate Capital LLC will acquire all outstanding shares of common stock of Sila Realty Trust, Inc. for $30.38 per share in an all-cash transaction valued at approximately $2.4 billion.

StubHub (NYSE: STUB), the leading global live events platform, today announced a new partnership with New Era, the international sports and lifestyle brand and the headwear of choice for fans across every major sport, to connect the two ways fans show up for live events: buying the ticket and wearing the gear.

It’s not every day a product from your morning routine ends up orbiting the Moon. But that’s exactly what happened with the Pitbull Diamond PRO by Skull Shaver.

AUSTIN, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector historically defined by long timelines and uncertain outcomes. As drug candidates advance closer to commercialization, scientific progress is no longer viewed solely as research expenditure but increasingly as a measurable financial asset. This shift is being reinforced by fair-value accounting under U.S. GAAP, which allows life sciences companies to reflect clinical progress, probability of success and commercialization timing as measurable balance sheet value. Leading companies, such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) (profile), are keenly aware of this evolution and are leveraging their expertise as pioneers in this space. Through its diversified pipeline and strategic holdings, including a 45% ownership stake in GMP Bio, which was recently measured at more than $1 billion enterprise value, the company exemplifies how advancing science can directly influence financial positioning. As the biotech sector increasingly aligns valuation with progress rather than revenue alone, Oncotelic provides a case study in how innovation is becoming a recognized asset class. Oncotelic joins an elite group of other key companies focused on advanced biotech platforms that target disease at the genetic or molecular level, including Sarepta Therapeutics Inc. (NASDAQ: SRPT), Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Denali Therapeutics Inc. (NASDAQ: DNLI). 

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123).

AUSTIN, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: For decades, GPS has operated as the invisible infrastructure underpinning modern warfare, enabling everything from precision-guided munitions to autonomous drone navigation. That assumption of reliability is now disappearing in real time. Across active conflict zones, satellite navigation signals are being jammed, spoofed and degraded at scale, turning one of the most trusted systems in defense into one of its most vulnerable. The consequences are immediate and measurable: Drones lose positioning, missions fail mid-operation and entire systems become ineffective in contested environments. As electronic warfare capabilities advance, GPS is increasingly becoming the first system adversaries attempt to disable, forcing a rapid reassessment of how modern platforms operate without it. In response, defense organizations worldwide are accelerating the search for alternatives that can function independently of satellite signals.

Wolo targeting approximately $5 million in revenue and $1 million in EBITDA by fiscal year 2027

National Life Group released its 2025 Annual Report, which highlights the company’s bigger, better, bolder approach to solid, steady and sustainable growth. It also released its popular Business Highlights which is a snapshot of the good the company did in 2025.

Translational study in metastatic triple-negative breast cancer (mTNBC) shows leronlimab-mediated CCR5 inhibition induces PD-L1 expression, modulates immune checkpoint signaling, and is associated with long-term survival in heavily pretreated patients

SOUTH SAN FRANCISCO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products, today announced upcoming presentations at the American Association for Cancer Research (AACR) Annual Meeting, April 17-22, 2026, in San Diego, Calif.

WEST PALM BEACH, Fla. and TOKYO, April 20, 2026 (GLOBE NEWSWIRE) -- Anthony, Linder & Cacomanolis, PLLC (“ALC”), a premier international capital markets and U.S. securities law firm, provides a strategic analysis of the March 12, 2026, Nasdaq Global Select Market debut of PayPay Corporation (Nasdaq: PAYP). The firm identifies the transaction as a seminal event for the Japanese "super-app" ecosystem and a repeatable structural blueprint for navigating the U.S. markets through the strategic alignment of Japanese domestic technology with U.S. institutional valuation expectations.

Contract modernizes and sustains the technology and infrastructure of Aircraft Armament Equipment (AAE), Support Equipment (SE), and Aerial Refueling System (ARS) integration for the MQ-25, building on SAIC’s 20-year partnership with the U.S. Navy

Strengthened Operations, Reinforced Retail Partnerships, and New Capital Position the Iconic Beauty House for Long-Term Success

Proprietary single-side operation addresses key customer pain points; ~strong pre-order demand and early distributor demand support 2026 revenue guidance

AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a global defense technology leader, today announced it was awarded a $14.6 million production contract by the U.S. Army for the VAPOR® Compact Long Endurance (CLE) unmanned aircraft system (UAS), its all-electric vertical takeoff and landing (VTOL) platform, under the Company-Level Directed Requirement (CoLvl DR) Small Uncrewed Aircraft System (SUAS), Tranche 2.

Grape Skin-Carob Synergy Antioxidant Systems Market Outlook 2026-2036 | Polyphenolic Blends, Shelf-Life Stability, and Bakery Applications Accelerate Growth By FMI Report

A week-long Earth Day promotion gives homeowners a timely opportunity to upgrade before summer watering season

Atlas Termite & Pest Control issues its annual Spring Pest Alert for Norman homeowners, warning of increased activity from termites, ants, mosquitoes, and rodents. The company provides professional inspections, treatments, and preventive strategies to protect homes and educate residents on seasonal pest threats.

Fayetteville, Georgia, April 20, 2026 (GLOBE NEWSWIRE) -- Camp Southern Ground founder Zac Brown and the organization’s Board of Directors today announced a leadership transition, naming Michael (“Mike”) Caimona as the nonprofit’s next Chief Executive Officer. Caimona is expected to begin in May 2026, succeeding longtime CEO Mike Dobbs, retiring after a decade of leadership.

Surf Air Mobility Inc. (NYSE: SRFM):

Partnership enables the integration of Turbo Energy’s AI-driven software into battery storage systems, supporting expansion of its high-margin international C&I pipeline

Company Advances Next-generation Patented MDMA Toward Patient Dosing in 2026

NEW YORK and TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today welcomed the White House Executive Order aimed at accelerating research, regulatory pathways, and patient access to psychedelic treatments.

Sojourn Accommodation announces an end-to-end serviced accommodation management service designed to help landlords transition from traditional long-term rentals to short-term lets, providing a hands-off route to higher returns as the Renters Reform Bill reshapes the UK property landscape.